Results

eNauka >  Rezultati >  Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes
Naziv: Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes
Autori: Xochelli, Aliki; Baliakas, Panagiotis; Kavakiotis, Ioannis; Agathangelidis, Andreas; Sutton, Lesley-Ann; Minga, Eva; Ntoufa, Stavroula; Tausch, Eugen; Yan, Xiao-Jie; Shanafelt, Tait;
Godina: 2017
Publikacija: Clinical Cancer Research
ISSN: 1078-0432 Clinical Cancer Research Pretraži identifikator
Izdavač: Denville, NJ : The Association
Tip rezultata: Naučni članak
Kolacija: vol. 23 br. 17 str. 5292-5301
DOI: 10.1158/1078-0432.ccr-16-3100
WoS-ID: 000409037300034
Scopus-ID: 2-s2.0-85029456308
PMID: 28536306
URI: https://enauka.gov.rs/handle/123456789/166765
https://imagine.imgge.bg.ac.rs/handle/123456789/1017
https://imagine.imgge.bg.ac.rs/handle/123456789/1611
URL: https://aacrjournals.org/clincancerres/article/23/17/5292/122592/Chronic-Lymphocytic-Leukemia-with-Mutated-IGHV4-34
Projekat: H "AEGLE, An analytics framework for integrated and personalized healthcare services in Europe", by the EU
H project "MEDGENET, Medical Genomics and Epigenomics Network" by the EU [692298]
Swedish Cancer Society
Swedish Research Council
Uppsala University
Uppsala University Hospital
Lion's Cancer Research Foundation
Selander's Foundation, Uppsala
Associazione Italiana per la Ricerca sul Cancro, Milano, Italy [IG15189, 9965, 10007]
Ricerca Finalizzata [RF-2010-2318823]
Ministero della Salute, Roma, Italy [RF-2011-02349712]
MEYS CZ project NPUII - CEITEC [LQ1601]
Novo Nordisk Fonden [NNF16OC0019302] Funding Source: researchfish
The Danish Cancer Society [R130-A8217] Funding Source: researchfish
Izvor metapodataka: Migracija
M-kategorija: 
21aM21a - Vodeći međunarodni časopis kategorije M21a

36
SCOPUSTM
19
PubMed CentralTM
20
OpenCitations
33
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.